Literature DB >> 20530831

Characterization of oxidized phosphatidylethanolamine derived from RAW 264.7 cells using 4-(dimethylamino)benzoic acid derivatives.

Karin A Zemski Berry1, William W Turner, Michael S VanNieuwenhze, Robert C Murphy.   

Abstract

Recently, a derivative of PE, namely the 4-(dimethylamino)benzoic acid derivative has been developed with various isotope labeled variants that provided a universal precursor ion scan for diacyl, ether and plasmalogen PE lipids that can not be accomplished otherwise. This derivative was further investigated as a means to facilitate characterization of various oxidized phosphatidylethanolamine lipids by collision activation. Phospholipids derived from RAW 264.7 cells were treated with a free radical generating system to generate a complex mixture of oxidized and non-oxidized lipids that were separated by reversed-phase high-performance liquid chromatography and detected using a precursors of m/z 191 scan for the d(0)-DMABA-labeled control sample and a precursor of m/z 197 scan for the d(6)-DMABA-labeled oxidized sample. Collisional activation of the corresponding [M - H](-) ions permitted the identification of several chain shortened omega-aldehydes, as well as direct oxygen addition products including isoprostane PE and monohydroxy PE oxidized phospholipids that were not easily detected without the use of the DMABA derivatives. The stable isotope labeled derivatives permitted assessment of relative quantitative changes in oxidized lipids based upon ion abundance.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20530831      PMCID: PMC3086548          DOI: 10.1255/ejms.1083

Source DB:  PubMed          Journal:  Eur J Mass Spectrom (Chichester)        ISSN: 1469-0667            Impact factor:   1.067


  17 in total

1.  A rapid method of total lipid extraction and purification.

Authors:  E G BLIGH; W J DYER
Journal:  Can J Biochem Physiol       Date:  1959-08

2.  Structural identification of a novel pro-inflammatory epoxyisoprostane phospholipid in mildly oxidized low density lipoprotein.

Authors:  A D Watson; G Subbanagounder; D S Welsbie; K F Faull; M Navab; M E Jung; A M Fogelman; J A Berliner
Journal:  J Biol Chem       Date:  1999-08-27       Impact factor: 5.157

3.  Structural characterization of oxidized phospholipid products derived from arachidonate-containing plasmenyl glycerophosphocholine.

Authors:  N Khaselev; R C Murphy
Journal:  J Lipid Res       Date:  2000-04       Impact factor: 5.922

4.  Analysis of oxidized glycerophosphocholine lipids using electrospray ionization mass spectrometry and microderivatization techniques.

Authors:  K A Harrison; S S Davies; G K Marathe; T McIntyre; S Prescott; K M Reddy; J R Falck; R C Murphy
Journal:  J Mass Spectrom       Date:  2000-02       Impact factor: 1.982

Review 5.  Bioactive phospholipid oxidation products.

Authors:  G K Marathe; K A Harrison; R C Murphy; S M Prescott; G A Zimmerman; T M McIntyre
Journal:  Free Radic Biol Med       Date:  2000-06-15       Impact factor: 7.376

6.  Analysis of epoxyeicosatrienoic and monohydroxyeicosatetraenoic acids esterified to phospholipids in human red blood cells by electrospray tandem mass spectrometry.

Authors:  T Nakamura; D L Bratton; R C Murphy
Journal:  J Mass Spectrom       Date:  1997-08       Impact factor: 1.982

Review 7.  Electrospray mass spectrometry of phospholipids.

Authors:  Melissa Pulfer; Robert C Murphy
Journal:  Mass Spectrom Rev       Date:  2003 Sep-Oct       Impact factor: 10.946

8.  Electrospray ionization tandem mass spectrometry of glycerophosphoethanolamine plasmalogen phospholipids.

Authors:  Karin A Zemski Berry; Robert C Murphy
Journal:  J Am Soc Mass Spectrom       Date:  2004-10       Impact factor: 3.109

9.  Non-cyclooxygenase-derived prostanoids (F2-isoprostanes) are formed in situ on phospholipids.

Authors:  J D Morrow; J A Awad; H J Boss; I A Blair; L J Roberts
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-15       Impact factor: 11.205

10.  Collision-induced dissociation of F2-isoprostane-containing phospholipids.

Authors:  K A Kayganich-Harrison; D M Rose; R C Murphy; J D Morrow; L J Roberts
Journal:  J Lipid Res       Date:  1993-07       Impact factor: 5.922

View more
  6 in total

Review 1.  Oxidative lipidomics coming of age: advances in analysis of oxidized phospholipids in physiology and pathology.

Authors:  Corinne M Spickett; Andrew R Pitt
Journal:  Antioxid Redox Signal       Date:  2015-03-26       Impact factor: 8.401

Review 2.  New families of bioactive oxidized phospholipids generated by immune cells: identification and signaling actions.

Authors:  Valerie B O'Donnell; Robert C Murphy
Journal:  Blood       Date:  2012-07-16       Impact factor: 22.113

3.  Lipidomic profiling of sinus mucosa from patients with chronic rhinosinusitis.

Authors:  Farbod Fazlollahi; Kessiri Kongmanas; Nongnuj Tanphaichitr; Jon Mallen-St Clair; Quinton Gopen; Kym F Faull; Jeffrey D Suh
Journal:  Clin Transl Sci       Date:  2015-01-15       Impact factor: 4.689

4.  Comprehensive lipidome profiling of isogenic primary and metastatic colon adenocarcinoma cell lines.

Authors:  Cassie J Fhaner; Sichang Liu; Hong Ji; Richard J Simpson; Gavin E Reid
Journal:  Anal Chem       Date:  2012-10-10       Impact factor: 6.986

5.  Lipidomic profiling of mastoid bone and tissue from patients with chronic otomastoiditis.

Authors:  Farbod Fazlollahi; Kessiri Kongmanas; Nongnuj Tanphaichitr; Jeffrey Suh; Kym Faull; Quinton Gopen
Journal:  Int Arch Otorhinolaryngol       Date:  2014-12-08

Review 6.  Lipoxidation in cardiovascular diseases.

Authors:  Erica Gianazza; Maura Brioschi; Alma Martinez Fernandez; Cristina Banfi
Journal:  Redox Biol       Date:  2019-02-25       Impact factor: 11.799

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.